Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.40    0.00 (0.00%)
Bid:
4.40
Ask:
4.525
Spread: 0.125 (2.841%)
Market Cap: £211.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Directorate Change

31 Jul 2017 07:00

RNS Number : 5385M
Seeing Machines Limited
31 July 2017
 

Seeing Machines Limited

("Seeing Machines" or "the Company")

 

Directorate Change

 

31 July 2017

 

Seeing Machines (AIM: SEE), an industry leader in computer vision based technologies which enable machines to see, understand and assist people, announces that Peter Housden has tendered his resignation as Non-executive Director to allow him to spend more time on other commitments. He will step down from the Board with immediate effect.

 

Seeing Machines Executive Chairman, Ken Kroeger commented: "On behalf of the Board, we would like to acknowledge the contribution of Peter Housden to the Company as a director over the past 16 months. His experience and support has been valuable in that time and we wish him all the best in his future endeavours."

 

Enquiries:

 

Seeing Machines Limited

www.seeingmachines.com / +61 2 6103 4700

 

 

Mike McAuliffe, CEO

Mike.McAuliffe@seeingmachines.com

Media enquiries

 

Sophie.Nicoll@seeingmachines.com

finnCap Ltd

 

Ed Frisby / Emily Watts, Corporate Finance

+44 20 7220 0500

Tim Redfern / Richard Chambers, Corporate Broking

 

 

 

Canaccord Genuity Limited

 

 

 

Simon Bridges

+44 20 7423 8000

Richard Andrews

Alexander Napier

 

 

 

 

 

 

 

About Seeing Machines

 

Seeing Machines, (AIM: SEE) is an industry leader in computer vision based technologies which enable machines to see, understand and assist people. With more than 17 years of deep domain experience, Seeing Machines deploys its proprietary computer vision platform to deliver precision tracking and analysis of heads, faces and eyes. A primary application today is Driver Monitoring Systems (DMS) to detect and manage drowsiness, distraction and other cognitive states which is key to the safe adoption of Automotive ADAS and Autonomous Driving as well as our pioneering Guardian Fleet safety solution. A further application is real-time delivery of precision eye tracking in real world conditions, such as normalizing for all light conditions, required for next generation displays and human machine interfaces. The company delivers its Machine Learning Vision platform in a range of solutions from Embedded software to Fovio processors to Guardian Fleet products, delivering its roadmap of human sensing and understanding. Guardian combines an in-cabin safety intervention system with cloud telematics monitoring & analytics services, which prevents accidents and saves costs and lives. Seeing Machines' technology has been adopted by global industry leaders across the market spectrum. Seeing Machines is headquartered in Canberra, Australia and currently has offices and people in Melbourne, Tucson, Silicon Valley, Detroit and the UK.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKMGFNKMGGNZG
Date   Source Headline
22nd Mar 20239:16 amRNSPDMR Shareholding
17th Mar 20239:03 amRNSDirector/PDMR Shareholding
16th Mar 202311:12 amRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPDMR Shareholding
14th Mar 20237:00 amRNSPDMR Shareholding
13th Mar 20239:24 amRNSNo exposure to Silicon Valley Bank
9th Mar 20236:09 pmRNSDirector/PDMR Shareholding
8th Mar 20233:33 pmRNSDirector/PDMR Shareholding
8th Mar 20233:30 pmRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSHalf year results and financial report
22nd Feb 20237:00 amRNSHalf year trading update and quarterly KPIs
15th Feb 20237:00 amRNSNotice of Results & Investor Presentation
8th Feb 20239:46 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSSeeing Machines and Mobileye to target Aftermarket
26th Jan 20239:36 amRNSDirector/PDMR Shareholding
25th Jan 202310:24 amRNSDirector/PDMR Shareholding
16th Jan 202310:28 amRNSDirector/PDMR Shareholding
13th Jan 20238:50 amRNSDirector/PDMR Shareholding
12th Jan 202310:05 amRNSDirector/PDMR Shareholding
11th Jan 202311:19 amRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSLaunch of Silicon Platform with OMNIVISION
4th Jan 20237:00 amRNSThree Collaborations to be showcased at CES 2023
3rd Jan 20237:00 amRNSSeeing Machines to exhibit DMS & OMS at CES 2023
22nd Dec 20227:02 amRNSSeeing Machines awarded additional OEM program
7th Dec 20229:01 amRNSPDMR Shareholding
6th Dec 20228:58 amRNSPDMR Shareholding
5th Dec 20227:00 amRNSPDMR Shareholding
2nd Dec 20227:00 amRNSPDMR Shareholding
29th Nov 20223:31 pmEQSSeeing Machines CEO talks new performance indicators and focus on annual growth
29th Nov 202210:43 amRNSPDMR Shareholding
28th Nov 20228:53 amRNSResult of AGM
24th Nov 202212:43 pmRNSPDMR Shareholding
23rd Nov 20227:00 amRNSKey Performance Indicators Q1 FY 2023
21st Nov 202211:46 amRNSPDMR Shareholding
18th Nov 20227:00 amRNSPDMR Shareholding
16th Nov 20227:00 amRNSPDMR Shareholding
14th Nov 20227:00 amRNSPDMR Shareholding
11th Nov 20227:00 amRNSAppointment of Chief Financial Officer
1st Nov 202211:17 amRNSDirector/PDMR Shareholding
27th Oct 20228:18 amRNSNotice of AGM
27th Oct 20227:00 amRNSYear End Results – FY2022
6th Oct 20227:00 amRNSExclusive agreement with Magna & US$65m investment
15th Sep 20228:50 amRNSTown Hall (Revised Date)
9th Sep 20227:30 amRNSPostponement of London presentation
16th Aug 20227:00 amRNSSeeing Machines London presentation
15th Aug 20227:00 amRNSFY2022 trading update
2nd Aug 202212:30 pmRNSInvestor newsletter update
16th Jun 20227:00 amRNSSeeing Machines awarded additional OEM program
6th Jun 20227:22 amRNSNew Tier One contract takes OEM customers to 10
10th May 20227:00 amRNSSeeing Machines appointment with Japanese OEM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.